Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the trendy-news-pro domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/u144920493/domains/currencyveda.com/public_html/wp-includes/functions.php on line 6121
IPO Alert: NTPC Green Energy's ₹10,000 Crore IPO Approved by SEBI - CurrencyVeda
TOP NEWS

IPO Alert: NTPC Green Energy’s ₹10,000 Crore IPO Approved by SEBI

NTPC Green Energy

October 28, 2024

New Delhi, India

IPO Alert

NTPC Green Energy Ltd, a subsidiary of NTPC Ltd, has received the go-ahead from the Securities and Exchange Board of India (SEBI) to launch a ₹10,000 crore initial public offering (IPO). This IPO consists entirely of new equity shares, with a reserved portion and discount available for qualifying employees.

  • IPO Size: ₹10,000 crore
  • Share Value: Face value of ₹10 per share
  • Primary Use of Proceeds:
    • Investment in NTPC Renewable Energy Ltd (NREL)
    • Debt repayment
    • General corporate purposes

Company Background

As of June 30, 2024, NTPC Green Energy is India’s largest public sector renewable energy entity (excluding hydro). It manages:

  • Operating Projects: 37 solar and 9 wind projects
  • Under Construction: 31 renewable projects across 7 states, with a total contracted capacity of 11,771 MW

Financial Highlights

NTPC Green Energy has shown impressive growth:

  • Revenue Growth: Up 46.82% from ₹910.42 crore in FY22 to ₹1,962.60 crore in FY24
  • Profit After Tax (PAT): Increased at a CAGR of 90.75%, reaching ₹344.72 crore in FY24
  • Q1 FY25 (June 2024): Revenue from operations at ₹578.44 crore, PAT at ₹138.61 crore

Lead Managers and Registrar

The offering is managed by:

  • Lead Managers: IDBI Capital, HDFC Bank, IIFL Securities, Nuvama Wealth Management
  • Registrar: KFin Technologies

Sun Pharma Q2 FY25 Results: Net Profit Rises 28% YoY, Driven by Strong Sales Growth

Latest Q2 Results

Currency Market Live Updates

Disclaimer:

CurrencyVeda provides this news article for informational purposes only. We do not offer investment advice or recommendations. Before making any investment decisions, please conduct thorough research, consult with financial experts, and carefully consider your financial situation, risk tolerance, and investment goals. Investing in the stock market carries risks, and it’s essential to make informed choices based on your individual circumstances. CurrencyVeda is not liable for any actions taken based on the information provided in this article.